	Determinants of self-management in Multiple Sclerosis: Insights from a Tunisian cross-sectional study. Mult Scler Relat Disord Rebei Y, Souissi A, Aissa A, Gharbi A, Abida Y, Atrous A, Kacem I, Gargouri A, Mrabet S, Jomli R, Gouider R. PMID: 42241784 [PubMed - as supplied by publisher]
	Retinal Optical Coherence Tomography Longitudinal Measures as Prognostic Biomarkers in Multiple Sclerosis: Systematic Review and Meta-Analysis. Neurol Neuroimmunol Neuroinflamm El Ayoubi NK, Ismail A, Sader G, Abi Chakra N, El Ahdab J, Abboud J, Khoury SJ. PMID: 42241647 [PubMed - as supplied by publisher]
	Quantitative MRI Biomarkers of Myelin: Cross-Validation and Diagnostic Performance in Multiple Sclerosis. NMR Biomed Lo J, Chan N, Tran D, Athertya JS, Cheraghi M, Shin SH, Bydder GM, Ma Y. PMID: 42240060 [PubMed - in process]
	Neuroinflammation at the Crossroads of Neurodegeneration: The Roles of Microglia and Astrocytes in Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis. Neurosciences (Riyadh) Almikhlafi MA. PMID: 42238675 [PubMed - in process]
	Suprapubic catheter insertion in people with multiple sclerosis: long-term complications and survival in a retrospective cohort study. J Rehabil Med Grandidge L, Mohamed Abu Baker A, Kennish S, Nair KPS. PMID: 42237591 [PubMed - in process]
	Validation of rule-based detection methods for relapse in multiple sclerosis. BMC Med Inform Decis Mak Alfakhri A, Almadani O, Alrwisan A, Albalawi O, Alshihayb T, Albogami Y, Alkahtani S, Alkhalifah R, Al Malik Y, Abulaban A, Althunian T. PMID: 42237144 [PubMed - as supplied by publisher]
	Letter to the editor on Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC study. J Neurol Sci Zahra E, Azhar A. PMID: 42235141 [PubMed - as supplied by publisher]
	Cognitive and structural brain changes in ofatumumab-treated multiple sclerosis: A longitudinal study. Neurotherapeutics Zanghì A, Di Filippo PS, Robusto C, Moretti MC, Avolio C, D'Amico E. PMID: 42235093 [PubMed - as supplied by publisher]
	Structural MRI signature of late- versus adult-onset multiple sclerosis: a multiparametric study. J Neurol Tedone N, Preziosa P, Pagani E, Meani A, Mistri D, Esposito F, Filippi M, Rocca MA. PMID: 42234209 [PubMed - in process]
	Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis. Per Med Mariki A, Mousavi SM, Anne Kohlmeier K, Kamali H, Shabani M. PMID: 42233619 [PubMed - as supplied by publisher]
	Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression. J Neuroinflammation Jiang Y, Xiao J, Kockum I, Stridh P, Liu Q, Olsson T, Alfredsson L, Jiang X. PMID: 42231304 [PubMed - as supplied by publisher]
	MANDIBULAR BONE MICROARCHITECTURE IN PATIENTS WITH MULTIPLE SCLEROSIS: A FRACTAL ANALYSIS STUDY. J Stomatol Oral Maxillofac Surg Yarba, Yurtta. PMID: 42229719 [PubMed - as supplied by publisher]
	Inner Plexiform Layer Microstructure Is Altered in Multiple Sclerosis. Invest Ophthalmol Vis Sci Emfietzoglou M, Correa VSMC, Sakuno G, Frances S, Bantounou MA, Baroutis KG, Papadopoulos D, Charonis A, Vavvas DG. PMID: 42227806 [PubMed - indexed for MEDLINE]
	Association of self-efficacy and self-management with multiple sclerosis patients' quality of life: a descriptive-analytical study. Neurodegener Dis Manag Atapour M, Maghaminejad F, Ghiyasvandian S, Rahimzadeh M. PMID: 42227717 [PubMed - as supplied by publisher]
	Bcl-2 as a Double-edged Sword for the Treatment of Multiple Sclerosis: A Systematic Review. CNS Neurol Disord Drug Targets Lashgari NA, Badrabadi F, Rouhollahi N, Kheirabad SS, Roudsari NM. PMID: 42227475 [PubMed - as supplied by publisher]
	Proteome-wide Mendelian Randomization and Colocalization Nominate CD58, PARP1, and Immune Co-stimulatory Pathways as Genetically Supported Targets for Multiple Sclerosis. Curr Neuropharmacol Wang Z, Sun Y, Bai Z, Li M, Kong D, Wu G. PMID: 42227395 [PubMed - as supplied by publisher]
	A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis. Mult Scler Benallegue N, Rollot F, Iaffaldano P, Lucisano G, Simone M, Lugaresi A, Casey R, Cocco E, Vukusic S, De Luca G, Mathey G, Patti F, Maillart E, Amato MP, Michel L, Fantozzi R, Ciron J, De Robertis F, De Sèze J, Coniglio MG, Ruet A, Filippi M, Labauge P, Crisafulli SG, Zephir H, Ferraro D, Papeix C, Lebrun-Frenay C, Trojano M, Laplaud DA. PMID: 42226562 [PubMed - as supplied by publisher]
	Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion. Eur J Neurol Alping P, Öberg Sysojev A, Piehl F, Frisell T. PMID: 42226439 [PubMed - indexed for MEDLINE]
	Deep learning-based neuroanatomical profiling reveals population-specific brain changes in multiple sclerosis: a large-scale Middle Eastern study. BMC Med Imaging Bawil MB, Shamsi M, Bavil AS. PMID: 42226149 [PubMed - as supplied by publisher]
	A comparative study of deep learning for cortical lesion MRI segmentation with explainability analysis in multiple sclerosis. Neuroimage Clin Molchanova N, Cagol A, Ocampo-Pineda M, Lu PJ, Weigel M, Chen X, Beck ES, Tsagkas C, Reich DS, Bulcke CV, Stölting A, Borrelli S, Maggi P, Lugo SB, Lemay DR, Depeursinge A, Granziera C, Müller H, Gordaliza PM, Bach Cuadra M. PMID: 42224860 [PubMed - as supplied by publisher]

Articles 1 - 20 / 44142

Page 1 of 2208



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy